Table 5 Success in achieving target values in our study and in the EUROASPIRE IV study
High-risk patients | Three Generations for Health Study | EUROASPIRE IV | ||
|---|---|---|---|---|
On target | ||||
Risk factor and target value | Total | Male | Female | Total |
Total cholesterol: < 4.5 mmol/l | 16.1% (n = 1388/8610) | 18.6% (n = 744/3995) | 14.0% (n = 644/4615) | |
LDL-cholesterol: < 2.5 mmol/l | 16.8% (n = 1426/8478) | 18.1% (n = 707/3916) | 15.8% (n = 719/4562) | 18.4% (n = 763/4137) |
HDL-cholesterol: male: > 1.0 mmol/l, female: > 1.3 mmol/l | 82.2% (n = 7075/8610) | 90.3% (n = 3607/3995) | 75.1% (n = 3468/4615) | |
Triglyceride: < 1.7 mmol/l | 66.3% (n = 5710/8610) | 61.5% (n = 2455/3995) | 70.5% (n = 3255/4615) | |
Blood pressure: < 140/90 mmHg (diabetes: < 140/85 mmHg. Nephropathy + proteinuria: < 130/80 mmHg) | 63.4% (n = 5439/8584) | 56.8% (n = 2261/3984) | 69.1% (n = 3178/4600) | 44.7% (n = 2031/4540) |
HbA1c < 7% (patients with type 2 diabetes) | 57.3% (n = 110/192) | 51.6% (n = 50/97) | 63.2% (n = 60/95) | 58.5% (n = 689/1177) |
BMI < 27 kg/m2 | 48.5% (n = 4155/8570) | 41.8% (n = 1665/3980) | 54.3% (n = 2490/4590) | |
BMI < 25 kg/m2 | 31.1% (n = 2667/8570) | 22.6% (n = 899/3980) | 38.5% (n = 1768/4590) | |
Waist circumference: (male: < 102 cm, female: < 88 cm) | 44.4% (n = 3378/7606) | 55.1% (n = 1957/3549) | 35.0% (n = 1421/4057) | 36.1% (n = 1585/4392) |